Results 41 to 50 of about 4,266 (136)
Targeted Therapy and Immunotherapies in Hepatocellular Carcinoma: Mechanisms and Clinical Studies
MedComm, Volume 7, Issue 5, May 2026.The mechanism of multiple signaling pathways and their related targeted inhibitors in HCC. (A) The mechanism of Ras/Raf/MEK/ERK signaling pathway and its related targeted inhibitors; (B) the mechanism of PI3K/AKT/mTOR signaling pathway and its crosstalk with other pathways and its related targeted inhibitors; (C) the mechanism of JAK/STAT signaling ...
Penghui He +9 more
wiley +1 more source
Castlemans Disease - A Rare Cause of Pyrexia of Unknown Origin (PUO): Case Report
Bangabandhu Sheikh Mujib Medical University Journal, 2010 Pyrexia of unknown origin (PUO) is a common problem in medical practice. Patients suffer from fever for long period but initial relevant investigations remain normal. Infection is the most common cause of PUO in developing countries.
Nusrat Sultana +5 more
doaj +1 more source
Biopharmaceuticals for Cancer Treatment: An Update
Cancer Medicine, Volume 15, Issue 4, April 2026.ABSTRACT Cancer is one of the most debilitating diseases, causing profound physical and psychological impacts on patients. The global number of cancer patients has been steadily rising over the last few decades. The development of effective cancer therapies remains the primary focus in life science research, requiring a precise understanding of ...
Anupom Deb Nath +6 more
wiley +1 more source
TAFRO syndrome: current perspectives
Journal of Blood Medicine, 2018 Kentaro Sakashita,1,2 Kengo Murata,2 Mikio Takamori2 1Department of Internal Medicine, Tokyo Metropolitan Matsuzawa Hospital, 2Department of Respiratory Medicine, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan Abstract: Multicentric Castleman’
Sakashita K, Murata K, Takamori M
doaj
Castleman’s disease mimicking lymph node metastases in a young woman with laryngeal cancer
Contemporary Oncology, 2016 Laryngeal cancer occurs rarely in adolescents and young people. Castleman’s disease is a rare lymphoproliferative disorder of uncertain etiopathogenesis and heterogeneous clinicopathological forms.
Krystyna Serkies +4 more
doaj +1 more source
Castleman’s disease – a case report
Videosurgery and Other Miniinvasive Techniques, 2011 Angiofollicular lymphoid hyperplasia (Castleman’s disease) is a very rare disease of lymphatic tissue, manifested by overgrowth of B lymphocytes and plasma cells in lymph nodes.
Maciej Wilczak +2 more
doaj
Castleman’s Disease in the HIV-Endemic Setting [Retraction]
Cancer Management and Research, 2020 Mahroug E, Sher-Locketz C, Desmirean M, et al. Cancer Manag Res. 2018;10:4553— 4563. The Editor-in-Chief and Publisher of Cancer Management and Research wish to retract the published article.
Mahroug E +5 more
doaj
[Mesenteric abscess due to Chryseobacterium meningosepticum revealing mesenteric Castleman´s disease in an immunocompetent young adult]. [PDF]
Pan Afr Med J, 2022 Banza MI +7 more
europepmc +1 more source
HIV-associated multicentric Castleman’s disease
Rare Tumors, 2012 Multicentric Castleman’s disease (MCD) is a rare lymphoproliferative disorder. It is found with higher frequency in patients with HIV infection, with systemic symptoms and poor prognosis.
Wilson Josè Couto +3 more
doaj +1 more source
Calcifying fibrous pseudotumor in association with hyaline vascular type Castleman′s disease
Indian Journal of Pathology and Microbiology, 2009 Calcifying fibrous pseudotumor is a recently described rare entity. It is considered as sclerosing end stage of inflammatory myofibroblastic tumor. An association with hyaline vascular type Castleman′s disease has also been described.
Azam Muhammad +2 more
doaj